 |
||||||||
 |
|
 |
 |
 |
 |
 |
|
|
Active Portfolio - EuropeA B C D E F G H I J K L M N O P Q R S T U V W X Y Z USA HISTORY PUBLIC |
|
|
7TM (Denmark) focuses on the discovery and development of
peptides and small molecules for obesity, based on core expertise in seven
transmembrane receptors and disease biology. http://www.7tm.com/ |
|
Bicycle Therapeutics (UK) is developing a novel technology for the creation of a new generation of biotherapeutics which combine the desirable features of small molecules and biopharmaceuticals. http://www.bicycletherapeutics.com/ | 
|
Protaffin AG (Austria) is developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures for the treatment of inflammatory and oncology diseases. http://www.protaffin.com |
|
Syntaxin Ltd. (UK)uses its substantial knowledge of
microbial proteins and expertise in protein engineering to discover and
develop novel biopharmaceuticals that block cell secretion in a variety of
cell types for the treatment of pain, nervous, respiratory and metabolic
diseases. http://www.syntaxin.com/ |